AZN logo

AstraZeneca PLC (AZN) Accounts payable

annual accounts payable:

$3.64B+$373.00M(+11.42%)
December 31, 2024

Summary

  • As of today (August 29, 2025), AZN annual accounts payable is $3.64 billion, with the most recent change of +$373.00 million (+11.42%) on December 31, 2024.
  • During the last 3 years, AZN annual accounts payable has risen by +$816.00 million (+28.90%).
  • AZN annual accounts payable is now at all-time high.

Performance

AZN Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

quarterly accounts payable:

$23.99B+$1.44B(+6.40%)
June 30, 2025

Summary

  • As of today (August 29, 2025), AZN quarterly accounts payable is $23.99 billion, with the most recent change of +$1.44 billion (+6.40%) on June 30, 2025.
  • Over the past year, AZN quarterly accounts payable has increased by +$3.52 billion (+17.22%).
  • AZN quarterly accounts payable is now at all-time high.

Performance

AZN quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AZN Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.4%+17.2%
3 y3 years+28.9%+34.6%
5 y5 years+105.2%+99.4%

AZN Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+42.8%at high+559.0%
5 y5-yearat high+105.2%at high+749.4%
alltimeall timeat high+631.3%at high+3733.4%

AZN Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$23.99B(+6.4%)
Mar 2025
-
$22.54B(+519.3%)
Dec 2024
$3.64B(+11.4%)
$3.64B(-83.2%)
Sep 2024
-
$21.68B(+6.0%)
Jun 2024
-
$20.46B(+3.9%)
Mar 2024
-
$19.70B(-12.0%)
Dec 2023
$3.27B(+28.1%)
$22.37B(+8.9%)
Sep 2023
-
$20.54B(+4.1%)
Jun 2023
-
$19.74B(+2.7%)
Mar 2023
-
$19.21B(+0.9%)
Dec 2022
$2.55B(-9.7%)
$19.04B(+7.6%)
Sep 2022
-
$17.69B(-0.7%)
Jun 2022
-
$17.82B(-0.2%)
Mar 2022
-
$17.86B(+532.6%)
Dec 2021
$2.82B(+20.2%)
$2.82B(-84.9%)
Sep 2021
-
$18.66B(+5.3%)
Jun 2021
-
$17.73B(+2.1%)
Mar 2021
-
$17.37B(+10.0%)
Dec 2020
$2.35B(+32.5%)
$15.79B(+17.7%)
Sep 2020
-
$13.41B(+11.5%)
Jun 2020
-
$12.03B(-4.8%)
Mar 2020
-
$12.63B(-9.7%)
Dec 2019
$1.77B(+3.1%)
$13.99B(+11.6%)
Sep 2019
-
$12.54B(-0.8%)
Jun 2019
-
$12.64B(-3.5%)
Mar 2019
-
$13.10B(+2.0%)
Dec 2018
$1.72B(-52.4%)
$12.84B(+16.8%)
Sep 2018
-
$10.99B(+0.7%)
Jun 2018
-
$10.91B(-4.9%)
Mar 2018
-
$11.48B(+217.9%)
Dec 2017
$3.61B(+20.8%)
$3.61B(-66.7%)
Sep 2017
-
$10.83B(+7.5%)
Jun 2017
-
$10.07B(+1.7%)
Mar 2017
-
$9.90B(-5.6%)
Dec 2016
$2.99B(-13.8%)
$10.49B(+5.3%)
Sep 2016
-
$9.96B(-2.9%)
Jun 2016
-
$10.26B(-8.2%)
Mar 2016
-
$11.17B(-4.2%)
Dec 2015
$3.47B(-0.7%)
$11.66B(+10.1%)
Sep 2015
-
$10.59B(-0.6%)
Jun 2015
-
$10.66B(+1.4%)
Mar 2015
-
$10.51B(-11.6%)
Dec 2014
$3.49B
$11.89B(+17.1%)
DateAnnualQuarterly
Sep 2014
-
$10.15B(-1.5%)
Jun 2014
-
$10.30B(-3.0%)
Mar 2014
-
$10.63B(+325.2%)
Dec 2013
$2.50B(+2.0%)
$2.50B(-73.0%)
Sep 2013
-
$9.24B(-4.1%)
Jun 2013
-
$9.64B(+1.9%)
Mar 2013
-
$9.47B(+286.5%)
Dec 2012
$2.45B(+13.6%)
$2.45B(-71.6%)
Sep 2012
-
$8.63B(-3.8%)
Jun 2012
-
$8.97B(+0.3%)
Mar 2012
-
$8.94B(+315.1%)
Dec 2011
$2.16B(-5.7%)
$2.16B(-73.2%)
Sep 2011
-
$8.03B(-5.7%)
Jun 2011
-
$8.51B(-1.8%)
Mar 2011
-
$8.67B(+279.6%)
Dec 2010
$2.28B(-1.3%)
$2.28B(-70.7%)
Sep 2010
-
$7.80B(+5.9%)
Jun 2010
-
$7.36B(+217.9%)
Dec 2009
$2.32B(+19.4%)
$2.32B(-39.7%)
Dec 2008
$1.94B(-44.5%)
$3.84B(-48.1%)
Jun 2008
-
$7.40B(+2.7%)
Mar 2008
-
$7.21B(+106.1%)
Dec 2007
$3.50B(+0.4%)
$3.50B(-48.1%)
Sep 2007
-
$6.73B(+93.3%)
Dec 2006
$3.48B(+10.2%)
$3.48B(+10.2%)
Dec 2005
$3.16B(+1.2%)
$3.16B(+1.2%)
Dec 2004
$3.13B(+1.3%)
$3.13B(+1.3%)
Dec 2003
$3.09B(-2.7%)
$3.09B(-2.7%)
Dec 2002
$3.17B(+33.0%)
$3.17B(+33.0%)
Dec 2001
$2.38B(-20.6%)
$2.38B(-20.6%)
Dec 2000
$3.00B(+201.1%)
$3.00B(-58.4%)
Sep 2000
-
$7.22B(+347.5%)
Dec 1999
$997.23M(+1.9%)
$1.61B(-40.7%)
Dec 1998
$978.31M(+12.4%)
-
Jun 1998
-
$2.72B(+211.5%)
Dec 1997
$870.42M(+6.2%)
$874.50M(+6.6%)
Dec 1996
$819.71M(-0.8%)
$820.29M(-0.2%)
Dec 1995
$825.98M(+4.3%)
$822.05M(-67.9%)
Jun 1995
-
$2.56B(+224.1%)
Dec 1994
$791.64M(+26.3%)
$791.08M(+26.4%)
Dec 1993
$626.89M(+18.3%)
$625.70M
Dec 1992
$530.04M(+6.5%)
-
Dec 1991
$497.77M(-65.5%)
-
Dec 1990
$1.44B
-

FAQ

  • What is AstraZeneca PLC annual accounts payable?
  • What is the all time high annual accounts payable for AstraZeneca PLC?
  • What is AstraZeneca PLC annual accounts payable year-on-year change?
  • What is AstraZeneca PLC quarterly accounts payable?
  • What is the all time high quarterly accounts payable for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly accounts payable year-on-year change?

What is AstraZeneca PLC annual accounts payable?

The current annual accounts payable of AZN is $3.64B

What is the all time high annual accounts payable for AstraZeneca PLC?

AstraZeneca PLC all-time high annual accounts payable is $3.64B

What is AstraZeneca PLC annual accounts payable year-on-year change?

Over the past year, AZN annual accounts payable has changed by +$373.00M (+11.42%)

What is AstraZeneca PLC quarterly accounts payable?

The current quarterly accounts payable of AZN is $23.99B

What is the all time high quarterly accounts payable for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly accounts payable is $23.99B

What is AstraZeneca PLC quarterly accounts payable year-on-year change?

Over the past year, AZN quarterly accounts payable has changed by +$3.52B (+17.22%)
On this page